Skip to main content
Premium Trial:

Request an Annual Quote

Alpha Innotech Expects to Report $3M in Total Q2 Revenue

NEW YORK (GenomeWeb News) - Alpha Innotech expects to report at least $3.15 million in revenues for the quarter ended June 30, marking its fourth consecutive quarter of year-over-year revenue growth, the company said today.
 
The company expects to post more than a 25-percent increase from the $2.51 million in revenues reported in the same period in 2005.
 
"We are on track to attain profitability in the second half of this year and we expect to generate positive cash flow perhaps as soon as next quarter," said Haseeb Chaudhry, CEO of Alpha Innotech, in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more